HeartBeam Inc. Advances Cardiac Care with Two New Patents for 3D ECG Technology
TL;DR
HeartBeam's new patents enhance its competitive edge in remote cardiac diagnostics, offering a unique 3D ECG device and rhythm analysis algorithm for precise arrhythmia detection.
HeartBeam's 3D ECG device collects high-fidelity signals in three directions for on-demand symptom recording, with its rhythm algorithm enhancing diagnostic precision across monitoring systems.
HeartBeam's innovations in cardiac care technology promise to improve patient outcomes by enabling accurate, remote heart monitoring and timely medical intervention.
HeartBeam is revolutionizing cardiac care with a cable-free 3D ECG device and AI-enhanced diagnostics, aiming to make heart health management accessible anywhere.
Found this article helpful?
Share it with your network and spread the knowledge!
HeartBeam Inc. (NASDAQ: BEAT) has recently been issued two new U.S. patents, further cementing its role in the advancement of cardiac care technology. These patents cover the company's compact, cable-free 3D ECG device and a rhythm analysis algorithm designed to detect arrhythmias through continuous signal input. This development is pivotal as it enhances the company's intellectual property portfolio and supports its mission to revolutionize remote cardiac diagnostics.
The 3D ECG device, notable for its use of chest and finger electrodes to capture high-fidelity signals in three non-coplanar directions, is tailored for on-demand symptom recording and 12-lead ECG synthesis. Currently under FDA review, the device's software is backed by data from the VALID-ECG pivotal study, promising a new era of precision in cardiac diagnostics. The rhythm algorithm, compatible with various cardiac monitoring systems, improves diagnostic accuracy by initiating targeted data collection upon detecting abnormal rhythms.
With a total of 20 issued patents and 34 additional filings, HeartBeam is at the forefront of digital cardiac care innovation. The company's future plans include integrating AI capabilities to further enhance diagnostic accuracy, underscoring its commitment to transforming cardiac health management. This advancement is not just a milestone for HeartBeam but also a beacon of hope for patients worldwide, offering the potential for timely and accurate cardiac diagnostics outside traditional medical facilities.
Curated from InvestorBrandNetwork (IBN)
